terfenadine has been researched along with Myocardial Ischemia in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Criniti, A | 1 |
| Picard, S | 1 |
| Monti, F | 1 |
| Dawodu, AA | 1 |
| Ruvolo, G | 1 |
| Puddu, PE | 1 |
| Campa, PP | 1 |
1 other study available for terfenadine and Myocardial Ischemia
| Article | Year |
|---|---|
Cicletanine prevents the excitation-conduction blocks induced by terfenadine in ischemic myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Dimethyl Sulfoxide; Drug Interactions; Epoprostenol; Female; Guinea | 1999 |